Molecular mechanisms of cryptococcal meningitis

Related Experiment Video

Updated: May 23, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

Tong-Bao Liu1, David S Perlin, Chaoyang Xue

  • 1The Public Health Research Institute, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, NJ, USA.

Virulence
|March 31, 2012
PubMed

Insights

Fungal meningitis, particularly cryptococcal meningitis in HIV-1/AIDS patients, remains a high-mortality disease. This review details fungal CNS infection mechanisms, focusing on dissemination and blood-brain barrier invasion.

Area of Science:

  • Neuroscience
  • Infectious Diseases
  • Mycology

Background:

  • Fungal meningitis is a severe CNS infection, often fatal, especially in immunocompromised individuals.
  • Cryptococcal meningitis is the most prevalent form in HIV-1/AIDS patients, with high mortality despite antifungal treatments.
  • Understanding fungal dissemination and brain invasion is crucial for effective treatment strategies.

Purpose of the Study:

  • To review the molecular mechanisms of fungal meningitis, using cryptococcal meningitis as a model.
  • To elucidate the key steps involved in fungal central nervous system (CNS) infection.
  • To discuss host and microbial factors influencing fungal meningitis pathogenesis.

Main Methods:

  • Literature review focusing on molecular mechanisms of fungal meningitis.
  • Analysis of studies on cryptococcal meningitis pathogenesis in HIV-1/AIDS.
  • Synthesis of information on fungal dissemination and blood-brain barrier invasion.

Main Results:

  • Fungal meningitis pathogenesis involves bloodstream dissemination and subsequent invasion of the CNS via the blood-brain barrier.
  • Host immune status and fungal virulence factors significantly impact infection progression.
  • Current antifungal therapies have limitations in reducing the high mortality rates.

Conclusions:

  • Further research into the molecular intricacies of fungal CNS infection is essential.
  • Targeting fungal dissemination and brain invasion pathways may offer novel therapeutic strategies.
  • Improved understanding of host-pathogen interactions is key to combating fungal meningitis.

More Related Videos

Size Matters: Measurement of Capsule Diameter in Cryptococcus neoformans08:24

Size Matters: Measurement of Capsule Diameter in Cryptococcus neoformans

Published on: February 27, 2018

Automated Measurement of Cryptococcal Species Polysaccharide Capsule and Cell Body08:08

Automated Measurement of Cryptococcal Species Polysaccharide Capsule and Cell Body

Published on: January 11, 2018

Related Concept Videos

Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...